SC
LLY icon

Syon Capital’s Eli Lilly LLY Stock Holding History

Syon Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Buy
13,135
+316
+2% +$323K 0.69% 32
2026
Q1 		$11.8M Sell
12,819
-51
-0.4% -$51.7K 0.59% 35
2025
Q4 		$13.8M Sell
12,870
-383
-3% -$366K 0.69% 30
2025
Q3 		$10.1M Buy
13,253
+1,212
+10% +$902K 0.54% 36
2025
Q2 		$9.39M Buy
12,041
+371
+3% +$288K 0.62% 31
2025
Q1 		$9.64M Buy
11,670
+1,171
+11% +$974K 0.78% 30
2024
Q4 		$8.11M Sell
10,499
-763
-7% -$632K 0.73% 28
2024
Q3 		$9.98M Buy
11,262
+127
+1% +$114K 0.88% 21
2024
Q2 		$10.1M Sell
11,135
-15
-0.1% -$12K 0.93% 19
2024
Q1 		$8.67M Buy
11,150
+362
+3% +$258K 0.82% 21
2023
Q4 		$6.29M Buy
10,788
+1,274
+13% +$744K 0.64% 28
2023
Q3 		$5.11M Buy
+9,514
New +$4.9M 0.64% 28

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Syon Capital's LLY Position: Q2 2026 in Review

Syon Capital increased its Eli Lilly (LLY) stake by 2.5% in Q2 2026, buying an estimated $323K and bringing the position to 13,135 shares worth $15.8M. The position accounts for 0.69% of the portfolio, ranked #32.

Syon Capital first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Syon Capital held 13,135 shares of Eli Lilly worth $15.8M as of Q2 2026.
  • Syon Capital bought 316 Eli Lilly shares in Q2 2026, an estimated $323K.
  • Eli Lilly made up 0.69% of Syon Capital's portfolio in Q2 2026, its #32 holding.
  • Syon Capital first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.